HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Expands Proposed REACH Review List By 63 Ingredients

This article was originally published in The Rose Sheet

Executive Summary

Sunscreen ingredient benzophenone and nail ingredient methacrylic acid included on CoRAP draft list of new substances proposed for evaluation under REACH chemicals legislation. Substances are slated to be divided among EU member states for evaluation over next three years.

You may also be interested in...



ECHA Proposes Oxybenzone, Glycolic Acid For Next REACH Review

Sunscreen agent oxybenzone and cosmetic ingredient glycolic acid are among ECHA’s latest nominees for evaluation under REACH.

In Brief

California adds benzophenone and diethanolamine to its list of chemicals known or suspected to cause cancer or reproductive toxicity under the state’s Safe Cosmetics Program. More news in brief.

Danish NGO Wants Multinationals To Eliminate Endocrine Disruptors

The Danish Consumer Council pushes Denmark to institute a ban on 17 suspected endocrine disruptors, meanwhile holding up 58 personal-care brands that have eliminated the substances from their products as an example to multinationals. Denmark has already banned two of the alleged endocrine disruptors in personal-care products aimed at young children.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel